- Home
- MNSB vs CYBN Comparison
MNSB vs CYBN Comparison
Compare MNSB & CYBN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MNSB
- CYBN
- Stock Information
- Founded
- MNSB 2003
- CYBN 2019
- Country
- MNSB United States
- CYBN Canada
- Employees
- MNSB N/A
- CYBN N/A
- Industry
- MNSB Major Banks
- CYBN Pharmaceuticals and Biotechnology
- Sector
- MNSB Finance
- CYBN Health Care
- Exchange
- MNSB Nasdaq
- CYBN Nasdaq
- Market Cap
- MNSB 140.1M
- CYBN 147.4M
- IPO Year
- MNSB N/A
- CYBN N/A
- Fundamental
- Price
- MNSB $19.10
- CYBN $5.92
- Analyst Decision
- MNSB
- CYBN Strong Buy
- Analyst Count
- MNSB 0
- CYBN 4
- Target Price
- MNSB N/A
- CYBN $71.25
- AVG Volume (30 Days)
- MNSB 38.2K
- CYBN 1.1M
- Earning Date
- MNSB 10-27-2025
- CYBN 11-13-2025
- Dividend Yield
- MNSB 2.11%
- CYBN N/A
- EPS Growth
- MNSB N/A
- CYBN N/A
- EPS
- MNSB N/A
- CYBN N/A
- Revenue
- MNSB $69,367,000.00
- CYBN N/A
- Revenue This Year
- MNSB $23.19
- CYBN N/A
- Revenue Next Year
- MNSB $2.92
- CYBN N/A
- P/E Ratio
- MNSB N/A
- CYBN N/A
- Revenue Growth
- MNSB 9.71
- CYBN N/A
- 52 Week Low
- MNSB $15.00
- CYBN $4.81
- 52 Week High
- MNSB $22.98
- CYBN $11.08
- Technical
- Relative Strength Index (RSI)
- MNSB 51.34
- CYBN 45.93
- Support Level
- MNSB $18.15
- CYBN $5.52
- Resistance Level
- MNSB $19.54
- CYBN $6.30
- Average True Range (ATR)
- MNSB 0.46
- CYBN 0.34
- MACD
- MNSB 0.12
- CYBN -0.06
- Stochastic Oscillator
- MNSB 57.36
- CYBN 42.16
About MNSB MainStreet Bancshares Inc.
MainStreet Bancshares Inc is a bank holding company. It is focused on serving the borrowing, cash management and depository needs of small to medium-sized businesses, and professional practices and retail customers. The bank's products and services include business and consumer checking, premium interest-bearing checking, business account analysis, savings, certificates of deposit and other depository services, as well as a broad array of commercial, real estate and consumer loans.
About CYBN Cybin Inc.
Cybin Inc is a biopharmaceutical company involved in creating safe and effective therapeutics for patients to address a multitude of mental health issues. The Company is a clinical-stage neuropsychiatric company focused on advancing therapies, delivery mechanisms, novel compounds, and protocols as potential treatments for various psychiatric and neurological conditions. The Company is developing technologies and delivery systems aimed at improving the pharmacokinetics of its proprietary molecules while retaining the therapeutic benefit. These new molecules and delivery systems are expected to be studied through clinical trials to confirm safety and efficacy.